Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taro Pharmaceutical Industries Ltd. Ordinary Shares (NY:TARO)

42.97 UNCHANGED
Last Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 42.97
Bid (Size) 41.50 (1)
Ask (Size) 43.97 (50)
Prev. Close 42.97
Today's Range 42.97 - 42.97
52wk Range N/A - N/A
Shares Outstanding 37,584,631
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CORRECTING and REPLACING TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire

Performance

More News

Read More
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Earnings Preview For Taro Pharmaceutical Indus
Via Benzinga
Taro Pharmaceutical Indus Earnings Preview
Via Benzinga
TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024
Via InvestorPlace
Taro Provides Results for Year Ended March 31, 2024
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro to Release Full Year Results on May 20, 2024
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
From Kahn Swick & Foti, LLC
Via Business Wire
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
From Brodsky & Smith LLC
Via GlobeNewswire
Taro Provides Results for December 31, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
From Brodsky & Smith LLC
Via GlobeNewswire
Taro to Release Third Quarter Results on January 25, 2024
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For January 25, 2024
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE -
From Brodsky & Smith LLC
Via GlobeNewswire
TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Taro Provides Results for September 30, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For October 26, 2023
Via Benzinga
Taro to Release Second Quarter Results on October 26, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Provides Results for the Quarter Ended June 30, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro to Release First Quarter Results on July 26, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire

Frequently Asked Questions

Is Taro Pharmaceutical Industries Ltd. Ordinary Shares publicly traded?
Yes, Taro Pharmaceutical Industries Ltd. Ordinary Shares is publicly traded.
What exchange does Taro Pharmaceutical Industries Ltd. Ordinary Shares trade on?
Taro Pharmaceutical Industries Ltd. Ordinary Shares trades on the New York Stock Exchange
What is the ticker symbol for Taro Pharmaceutical Industries Ltd. Ordinary Shares?
The ticker symbol for Taro Pharmaceutical Industries Ltd. Ordinary Shares is TARO on the New York Stock Exchange
What is the current price of Taro Pharmaceutical Industries Ltd. Ordinary Shares?
The current price of Taro Pharmaceutical Industries Ltd. Ordinary Shares is 42.97
When was Taro Pharmaceutical Industries Ltd. Ordinary Shares last traded?
The last trade of Taro Pharmaceutical Industries Ltd. Ordinary Shares was at 06/21/24 07:00 PM ET
What is the market capitalization of Taro Pharmaceutical Industries Ltd. Ordinary Shares?
The market capitalization of Taro Pharmaceutical Industries Ltd. Ordinary Shares is 1.62B
How many shares of Taro Pharmaceutical Industries Ltd. Ordinary Shares are outstanding?
Taro Pharmaceutical Industries Ltd. Ordinary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.